EndoCare+ is a specialized pharmaceutical platform focused on biopharmaceutical, hormonal, endocrine, reproductive, metabolic, and specialty therapies in Yemen. We work across healthcare, regulatory, commercial, quality, and patient-safety functions to support reliable access to specialized medicines.
Cold-Chain Capability
Governance Framework
Supporting access to specialized medicines and safety reporting.
Providing reliable product and safety information.
Supporting responsible supply and distribution.
Operating within applicable regulatory and quality requirements.
EndoCare+ focuses on specialized pharmaceutical therapies and the systems required to support their responsible availability in the Yemeni healthcare market. Our activities bring together regulatory affairs, quality, distribution, medical engagement, commercial operations, and pharmacovigilance.
About EndoCare+Specialized therapeutic areas and portfolio development.
Explore 02Regulatory coordination and product authorization activities.
Explore 03Supporting appropriate access to medicines across healthcare channels.
Explore 04Scientific engagement and responsible commercial activities.
Explore 05Controlled storage, distribution and product integrity.
Explore 06Quality oversight, safety monitoring and adverse-event reporting.
ExploreOur therapeutic focus reflects the specialized healthcare needs we aim to support through appropriate products, professional engagement, quality systems, and reliable supply.
Explore Therapeutic FocusTemperature-controlled processes for products requiring specific storage conditions.
Batch-level controls supporting product identification and distribution oversight.
Structured processes designed to support reliable product availability.
Patient safety and product quality are integral to our pharmaceutical activities. Our quality and pharmacovigilance functions support the identification, documentation, assessment, and appropriate follow-up of product quality and safety information.
We support healthcare professionals through scientific and product information, appropriate medical engagement, and access to relevant safety and quality reporting channels.
EndoCare+ operates in cooperation with Sabrah Pharma within the broader Sabrah pharmaceutical platform in Yemen, benefiting from established pharmaceutical experience and operational resources.
Explore the GroupEndoCare+ welcomes appropriate collaborations with pharmaceutical and healthcare organizations whose products and objectives align with our therapeutic focus, quality requirements, and capabilities in Yemen.
Partnership ModelExplore our services, therapeutic focus, safety information, and healthcare resources.